The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Assets Trust Regulatory News (PNL)

Share Price Information for Personal Assets Trust (PNL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.50
Bid: 486.00
Ask: 487.00
Change: -2.00 (-0.41%)
Spread: 1.00 (0.206%)
Open: 487.00
High: 487.50
Low: 485.00
Prev. Close: 487.50
PNL Live PriceLast checked at -
Personal Assets is an Investment Trust

To protect and increase shareholders' funds over the long-term by investing in equities, fixed income securities, cash and cash equivalents (which may include gold).

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

20 Nov 2020 07:00

RNS Number : 9459F
Personal Assets Trust PLC
20 November 2020
 

To: RNS

From: Personal Assets Trust plc

LEI: 213800Z7ABM7RLQ41516

Date: 20 November 2020

 

 

Interim Report for the Six months ended 31 October 2020 (Unaudited)

 

Financial Summary

 

Personal Assets Trust ("PAT") is an investment trust run expressly for private investors.

 

The Company's investment policy is to protect and increase (in that order) the value of shareholders' funds per share over the long term.

 

Over the six months to 31 October 2020 PAT's net asset value per share ("NAV") rose by 2.9% to £438.67. PAT's share price rose by £7.00 to £440.00 over the same period, being a premium of 0.3% to the Company's NAV at that date.

 

During the period, PAT continued to maintain a high level of liquidity.

 

 

 

% as at

31 October

2020

% as at

30 April

2020

 

 

 

 

 

 

US TIPS

 

30.0

31.3

 

UK T-Bills

 

12.6

9.1

 

Gold Bullion

 

9.4

9.9

 

Property

 

0.2

0.2

 

UK cash

 

6.0

4.9

 

Overseas cash

 

0.0

0.0

 

Net current (liabilities) / assets

 

(0.4)

0.1

 

 

Total

 

57.8

55.5

 

 

 

Over the six months PAT's shares continued to trade close to NAV. We re-issued 43,546 Ordinary shares from Treasury and issued 228,350 new Ordinary shares (adding £121.5 million of capital) at a small premium.

      

 

Dividends are paid in July, October, January and April of each year. The first interim dividend of £1.40 per Ordinary share was paid to shareholders on 17 July 2020 and the second interim dividend of £1.40 was paid on 9 October 2020. A third interim dividend of £1.40 per Ordinary share will be paid to shareholders on 8 January 2021 and a fourth interim dividend of £1.40 per Ordinary share is expected to be paid in April 2021, making a total for the year of £5.60 per Ordinary share.

 

 

 Key Features

 

 

 

As at

31 October

2020

As at

30 April

2020

 

 

 

 

Market Capitalisation

 

£1,317.8m

£1,179.1m

Shareholders' Funds

 

£1,313.8m

£1,161.0m

Shares Outstanding

 

2,994,899

2,723,003

Liquidity (see fourth bullet point above)

 

57.8%

55.5%

Share Price

 

£440.00

£433.00

NAV per Share

 

£438.67

£426.36

FTSE All-Share Index

 

3,151.27

3,262.51

Premium to NAV

 

0.3%

1.6%

Earnings per Share

 

£2.03

£5.86⁽¹⁾

Dividend per Share

 

£2.80

£5.60⁽¹⁾

 

 

 

 

⁽¹⁾ Full Year.

 

 

 

Investment Manager's Report

 

Over the half year to 31 October 2020 the net asset value per share ("NAV") of Personal Assets Trust ("PAT") rose by 2.9% while the FTSE All-Share Index ("FTSE") fell by 3.4%. This was a surprisingly stable six months for stock markets following the remarkable period of Covid-induced collapse and subsequent rally that occurred in February, March and April. This apparently dull performance for the half year belies continued material divergence between technology stocks, along with companies seen as beneficiaries from lockdowns, versus the remainder that lagged. This has been a tale of two stock markets, commonly described as a 'K'- shaped recovery, with the U.S. market's largest five companies; Apple, Microsoft, Amazon, Facebook and Alphabet (Google's parent) driving returns disproportionately. Despite the anticipated rebound in the economy, we expect the recovery to be gradual as businesses reopen. However, as the post-Covid economy reveals itself, it may look different from previous economic recoveries with trends such as working from home, digital payments and the transition to a low carbon economy likely to accelerate.

 

Portfolio activity was very modest during the half year following the high activity of February and March, when we raised the Trust's equity exposure materially. We sold the Trust's investment in Coca-Cola, held since 2009, during the period due to what we believed to be persistent headwinds to volume growth over the long term. Carbonated soft drinks face a number of challenges, not least the environmental scrutiny faced by their packaging and a secular shift in consumer preferences towards healthier alternatives. Added to this is the more immediate threat to its cash flows from Coke's out-of-home consumption. We have concerns over balance sheet strength, free cash flow generation and the valuation. We also sold the residual holding in AG Barr. We acquired a holding in Becton Dickinson. Becton is a wonderfully diversified portfolio of small-ticket, repeat purchase items that are indispensable to healthcare globally. The opportunity to improve outcomes by bringing digital capabilities to bear on Becton's portfolio is one that appears as yet underappreciated but which the new CEO understands and articulates well. Growth in sales is underpinned by Becton's unrivalled competitive position and the increasing demand for medical devices in both developed markets with aging populations and developing markets where the provision of healthcare is becoming more sophisticated. The shares were acquired at an attractive valuation following a prolonged period of dull performance.

 

Whilst the shift towards digital payments has been occurring for some time, there is evidence that this is now accelerating as ecommerce becomes ubiquitous and governments around the world are shaping regulation to drive the share of digital payments, which incur less cost and help reduce crime. During the pandemic, cash has also become a vector for virus transmission, causing more merchants to accept card and encourage contactless payments. There are also substantial opportunities in digitising payments between businesses (B2B) and other channels such as bill payments and government disbursements in addition to the core C2B (consumer to business) payments which make up the majority of the card networks' businesses today. During the period we added to the Trust's holdings in American Express and Visa, both beneficiaries of these dynamics that we expect to strengthen as the economy begins to reopen.

 

Asset prices have been supported by aggressive monetary and fiscal policies, which are endeavouring to replace the collapse in demand resulting from the pandemic. Interest rates have been nailed to the floor indefinitely, making yielding assets relatively more attractive. The prospect of interest rates in the UK following Japan and Europe into negative territory, supports our longstanding thesis of a shift to negative real rates. Zero-bound yields in fixed income are less appealing but index-linked bonds and gold should provide protection against a financially repressive future. This said, there is no guarantee that either asset class will provide an offset to equities during short-term bouts of volatility, as conventional bonds once did. Correlations have now increased across the board, as was apparent during the weakness in March, and we are entering an era in which it will become harder to generate low risk, absolute returns. This will not change the way we manage the portfolio to achieve the Trust's aim; to protect and grow capital (in that order) but shareholders should prepare for greater short-term volatility in both absolute and relative terms.

 

Sebastian Lyon, Investment Manager

 

 

Portfolio as at 31 October 2020

 

 

 

 

S/holders' Funds

Valuation

Bought/(sold) in period

Gain/ (loss) in period

 

 

 

 

31 October 2020

 

 

Security

Country

Equity Sector

%

£'000

£'000

£'000

 

 

 

 

 

 

 

Equities

 

 

 

 

 

 

Microsoft

USA

Technology

5.2

67,919

-

6,159

Alphabet

USA

Technology

4.1

54,342

-

7,809

Unilever

UK

Food Producer

3.7

49,111

-

3,368

Nestlé

Switzerland

Food Producer

3.7

48,138

-

1,690

Philip Morris

USA

Tobacco

2.8

37,530

-

(2,836)

Visa

USA

Financial Services

2.8

36,813

3,134

(227)

Diageo

UK

Beverages

2.5

32,799

-

(3,309)

Medtronic

USA

Healthcare

2.4

32,407

-

79

American Express

USA

Financial Services

2.1

27,613

6,378

(575)

British American Tobacco

UK

Tobacco

2.1

27,319

-

(7,038)

Franco-Nevada

Canada

Mining

2.1

27,170

3,806

186

Berkshire Hathaway

USA

Insurance

2.0

26,698

-

1.268

Agilent Technology

USA

Healthcare

2.0

26,244

-

5,992

Procter & Gamble

USA

Household Products

1.7

21,862

-

2,569

Becton Dickinson

USA

Pharmaceuticals

1.4

18,007

19,074

(1,067)

Colgate Palmolive

USA

Personal Products

1.1

14,147

-

1,208

Experian

UK

Industrial

0.5

6,224

6,237

(13)

Coca-Cola

USA

Beverages

-

-

(11,421)

450

A.G. Barr

UK

Beverages

-

-

(4,400)

(534)

Total Equities

 

 

42.2

554,343

22,808

15,179

US TIPS

USA

 

30.0

393,610

30,785

(800)

UK T-Bills

UK

 

12.6

165,997

60,206

(110)

Gold Bullion

 

 

9.4

123,766

-

8,675

Total Investments

 

94.2

1,237,716

113,799

22,944

Property

 

 

0.2

2,105

406

-

Subsidiary

 

 

-

-

(2,793)

1,560

Other Assets

 

94.4

1,239,821

111,412

24,504

UK cash

 

6.0

79,181

n/a

n/a

Overseas cash

 

0.0

11

n/a

n/a

Net current liabilities

 

(0.4)

(5,251)

n/a

n/a

TOTAL PORTFOLIO

 

100.0

1,313,762

n/a

n/a

 

 

Geographic Analysis of Investments and Currency Exposure As At 31 October 2020

 

 

UK

USA

Canada

Switzerland

Total

 

%

%

%

%

%

Equities

9

27

2

4

42

Inflation-Linked Securities

-

30

-

-

30

T-Bills

13

-

-

-

13

Gold Bullion

-

9

-

-

9

Cash

6

-

-

-

6

Property

0

-

-

-

0

Net current liabilities

0

-

-

-

0

Total

28

66

2

4

100

Net currency exposure %

58

36

2

4

100

 

 

Statement of Principal Risks and Uncertainties

 

 

The Board believes that the principal risks to shareholders, which it seeks to mitigate through continual review of its investments and through shareholder communication, are events or developments which can affect the general level of share prices and other financial assets, including, for instance, inflation or deflation, economic recessions and movements in interest rates and currencies. There remain uncertainties resulting from the COVID-19 pandemic that may impact the Company, including investment risks surrounding the companies within the portfolio. The Board continues to work with the Investment Manager, PATAC and its other advisers to manage these risks as far as possible in these uncertain times.

Other risks faced, and the way in which they are managed, are described in more detail under the heading Principal Risks and Risk Management within the Strategic Report in the Company's Annual Report for the year ended 30 April 2020.

 

The Company's principal risks and uncertainties have not changed since the date of the Annual Report and are not expected to change for the remaining six months of the Company's financial year.

 

Going Concern

 

The Directors acknowledge that the situation surrounding the COVID-19 pandemic continues to create risks and uncertainties which may impact the Company. Nevertheless, the Directors believe, in the light of the controls and review processes noted above and bearing in mind the nature of the Company's business and assets, which are considered readily realisable if required, that the Company has adequate resources to continue operating for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

 

Related Party Transactions

Details of related party transactions are contained in the Annual Report for the year ended 30 April 2020. There have been no material changes in the nature and type of the related party transactions as stated within the Annual Report.

 

 

Directors' Responsibility Statement in Respect of the Interim Report

We confirm that to the best of our knowledge:

· the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the EU;

· the Investment Manager's Report include a fair review of the information required by the Disclosure Guidance and Transparency Rules ("DTR") 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements;

· the Statement of Principal Risks and Uncertainties is a fair review of the information required by DTR 4.2.7R; and

· the condensed financial statements include a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.

 

On behalf of the Board,

Iain Ferguson, Chairman

19 November 2020

 

 

 

For further information, contact:

 

Sebastian Lyon

Investment Manager

Tel: 0207 499 4030

 

Carron Dobson

PATAC Limited, Company Secretary

Tel: 0131 378 0500

 

 

 

Condensed Income Statement

For the six months ended 31 October 2020

 

 

(Unaudited)

 

Six months ended

 

31 October 2020

 

Revenue

Capital

 

 

Return

Return

Total

 

£'000

£'000

£'000

 

 

 

 

Investment income

8,263

-

8,263

Other operating income

-

-

-

Gains on investments held at fair value through profit or loss

-

22,944

22,944

Gain from discontinued operation

-

1,560

1,560

Foreign exchange gains

-

11,433

11,433

 

 

 

 

Total income

8,263

35,937

44,200

Expenses

(2,390)

(2,517)

(4,907)

 

 

 

 

Return before taxation

5,873

33,420

39,293

Taxation

(79)

-

(79)

 

 

 

 

Return for the period

5,794

33,420

39,214

 

 

 

 

Return per share

 

£2.03

£11.69

£13.72

 

The ''Return for the Period'' is also the ''Total Comprehensive Income for the period'', as defined in IAS1 (revised), and no separate Statement of Comprehensive Income has been presented.

The ''Total'' column of this statement represents the Company's Income Statement, prepared in accordance with International Financial Reporting Standards (''IFRSs'').

The Revenue Return and Capital Return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.

All items in the above statement derive from continuing operations other than the sale of the Company's subsidiary which is included as "Gain from discontinued operation". Details of the sale can be found in note 7. There are no other discontinued operations. Therefore, the post transaction profit from discontinued operations is £1,560,000.

 

 

Condensed Income Statement

For the six months ended 31 October 2019

 

 

(Unaudited)

 

Six months ended

 

31 October 2019

 

Revenue

Capital

 

 

Return

Return

Total

 

£'000

£'000

£'000

 

 

 

 

Investment income

12,070

-

12,070

Other operating income

107

-

107

Gains on investments held at fair value through profit or loss

-

25,866

25,866

Foreign exchange losses

-

(3,537)

(3,537)

 

 

 

 

Total income

12,177

22,329

34,506

Expenses

(2,031)

(2,176)

(4,207)

 

 

 

 

Return before taxation

10,146

20,153

30,299

Taxation

(1,341)

1,025

(316)

 

 

 

 

Return for the period

8,805

21,178

29,983

 

 

 

 

Return per share

 

£2.87

£9.01

£11.88

 

 

Condensed Income Statement

For the year ended 30 April 2020

 

 

(Audited)

 

 

Year ended

 

 

30 April 2020

 

 

Revenue

Capital

 

 

 

Return

Return

Total

 

 

£'000

£'000

£'000

 

 

 

 

 

 

Investment income

21,690

-

21,690

 

Other operating income

162

-

162

 

Gains on investments held at fair value through profit or loss

-

69,319

69,319

 

Foreign exchange losses

-

(16,260)

(16,260)

 

 

 

 

 

 

Total income

21,852

53,059

74,911

 

Expenses

(4,068)

(4,427)

(8,495)

 

 

 

 

 

 

Return before taxation

17,784

48,632

66,416

 

Taxation

(2,433)

1,444

(989)

 

 

 

 

 

 

Return for the period

15,351

50,076

65,427

 

 

 

 

 

 

Return per share

£5.86

£19.13

£24.99

 

 

 

 

        
 

 

Condensed Statement of Financial Position

As at 31 October 2020

 

 

(Unaudited)

(Unaudited)

(Audited)

 

31 October

31 October

30 April

 

2020

2019

2020

 

£'000

£'000

£'000

 

 

 

 

Non-current assets

 

 

 

 

Investments held at fair value through profit or loss

 

 

1,237,716

 

1,042,229

 

1,100,973

Property

2,105

1,628

1,699

Net current assets

73,941

58,681

58,294

 

 

 

 

Net assets

1,313,762

1,102,538

1,160,966

 

 

 

 

Total equity

1,313,762

1,102,538

1,160,966

 

 

 

 

Net asset value per Ordinary share

£438.67

£415.16

£426.36

 

 

 

 

 

 

Condensed Statement of Changes in Equity

For the six months ended 31 October 2020

 

 

 

 

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Six months

Six months

Year

ended

ended

ended

31 October

31 October

30 April

2020

2019

2020

£'000

£'000

£'000

 

 

 

 

 

 

 

Opening equity shareholders' funds

1,160,966

968,579

968,579

Return for the period

39,214

29,983

65,427

Ordinary dividends paid

(7,963)

(7,018)

(14,639)

Issue of Ordinary shares

121,545

110,994

171,240

Share buybacks

-

-

(29,641)

 

 

 

 

Closing equity shareholders' funds

1,313,762

1,102,538

1,160,966

 

 

 

 

 

 

 

Condensed Cash Flow Statement

For the six months ended 31 October 2020

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Six months

Six months

Year

ended

ended

ended

31 October

31 October

30 April

2020

2019

2020

£'000

£'000

£'000

 

 

 

Net cash inflow from operating activities

 

2,605

2,698

5,525

Net cash outflow from investing

 

 

 

activities

(92,380)

(94,851)

(97,794)

 

 

 

 

Net cash outflow before financing

 

 

 

activities

(89,775)

(92,153)

(92,269)

Net cash inflow from financing

 

 

 

 

activities

113,031

103,977

125,876

 

 

 

 

Net increase in cash and

 

 

 

cash equivalents

23,256

11,824

33,607

Cash and cash equivalents at the start of

 

 

 

the period

56,091

22,792

22,792

Effect of exchange rate changes

(155)

154

(308)

 

 

 

 

Cash and cash equivalents at the end of

 

 

 

the period

79,192

34,770

56,091

 

 

 

 

 

      

 

 

1. The condensed consolidated financial statements have been prepared in accordance with International Financial Reporting Standard ('IFRS') IAS 34 'Interim Financial Reporting' and the accounting policies set out in the statutory accounts of the Company for the year ended 30 April 2020. The condensed consolidated financial statements do not include all of the information required for a complete set of IFRS financial statements and should be read in conjunction with the consolidated financial statements of the Company for the year ended 30 April 2020, which were prepared under full IFRS requirements.

2. The return per Ordinary share figure is based on the net profit for the six months of £39,214,000 (six months ended 31 October 2019: net profit of £29,983,000; year ended 30 April 2020: net profit of £65,427,000) and on 2,858,320 (six months ended 31 October 2019: 2,523,148; year ended 30 April 2020: 2,617,987) Ordinary shares, being the weighted average number of Ordinary shares in issue during the respective periods.

3. In respect of the year ending 30 April 2021 the Board has declared a first interim dividend of £1.40 per Ordinary share, which was paid on 17 July 2020 and a second interim dividend of £1.40 per Ordinary share, which was paid on 9 October 2020. A third interim dividend of £1.40 per Ordinary share will be paid to shareholders on 8 January 2021 and a fourth interim dividend of £1.40 per Ordinary share is expected to be paid in April 2021, making a total for the year of £5.60 per Ordinary share. In respect of the year ended 30 April 2020 the Board declared four interim dividends of £1.40 per Ordinary share. This gave a total dividend for the year ended 30 April 2020 of £5.60 per Ordinary share.

4. At 31 October 2020 there were 2,994,899 Ordinary shares in issue (31 October 2019: 2,655,663; 30 April 2020: 2,723,003). During the six months ended 31 October 2020 the Company re-issued 43,546 Ordinary shares from Treasury and issued 228,350 new Ordinary shares.

 

5. The Board has considered the requirements of IFRS 8 'Operating Segments'. The Board is of the view that the Company is engaged in a single segment of business, being that of investing in equity shares, fixed interest securities and other investments, and that therefore the Company has only a single operating segment.

 

6. The Company held the following categories of financial instruments as at 31 October 2020:

 

 

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Investments

1,237,716

-

-

1,237,716

Current liabilities

-

(346)

-

(346)

Total

1,237,716

(346)

-

1,237,370

The above table provides an analysis of investments based on the fair value hierarchy described below and which reflects the reliability and significance of the information used to measure their fair value. The levels are determined by the lowest (that is, the least reliable or least independently observable) level of impact that is significant to the fair value measurement for the individual investment in its entirety as follows:

Level 1 reflects financial instruments quoted in an active market.

Level 2 reflects financial instruments the fair value of which is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique the variables of which include only data from observable markets. The Company's forward currency contract has been included in this level as fair value is achieved using the foreign exchange spot rate and forward points which vary depending on the duration of the contract.

Level 3 reflects financial instruments the fair value of which is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

The Company's subsidiary was sold on 30 September 2020.

There were no transfers of investments between levels in the period ended 31 October 2020.

The following table summarises the Company's Level 1 investments that were accounted for at fair value in the period to 31 October 2020.

 

 

(Level 1)

£'000

 

Opening book cost

884,917

Opening fair value adjustment

216,056

Opening valuation

1,100,973

Movement in the period:

 

Purchases at cost

285,662

Effective yield adjustment

452

Sales - proceeds

(172,315)

- gains on sales

4,664

Increase in fair value adjustment

18,280

Closing valuation at 31 October 2020

1,237,716

Closing book cost

1,003,380

Closing fair value adjustment

234,336

Closing valuation at 31 October 2020

1,237,716

 

Other aspects of the Company's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 30 April 2020.

The fair value of the Company's financial assets and liabilities as at 31 October 2020 was not materially different from their carrying values in the financial statements.

 

7. The Company's subsidiary was sold on 30 September 2020. Details of the sale are as follows:-

 

£'000

Total disposal consideration

2.943

Costs of disposal

(149)

Net consideration

2,794 *

Carrying amount of net assets sold

(1,234)

Gain on sale before taxation

1,560

Taxation

-

Gain on sale after taxation

1,560

\* The net consideration has been included in the Company's Condensed Cash Flow Statement under "Net cash outflow from investing activities".

 

8. These are not full statutory accounts in terms of Section 434 of the Companies Act 2006 and are unaudited. Statutory accounts for the year ended 30 April 2020, which received an unqualified audit report and which did not contain a statement under Section 498 of the Companies Act 2006, have been lodged with the Registrar of Companies. No full statutory accounts in respect of any period after 30 April 2020 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

9. A copy of the Interim Report is available on the Company's website at www.patplc.co.uk. A new website for the Company is expected to be launched shortly. Shareholder are encouraged to visit the website for further information on the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DGBDBISBDGGC
Date   Source Headline
24th May 20245:06 pmRNSTransaction in Own Shares
24th May 202412:05 pmRNSNet Asset Value(s)
23rd May 202412:43 pmRNSNet Asset Value(s)
22nd May 202411:29 amRNSNet Asset Value(s)
21st May 202412:15 pmRNSNet Asset Value(s)
20th May 20245:38 pmRNSTransaction in Own Shares - Replacement
20th May 20244:45 pmRNSTransaction in Own Shares
20th May 202411:53 amRNSNet Asset Value(s)
17th May 20244:22 pmRNSTransaction in Own Shares
17th May 202411:33 amRNSNet Asset Value(s)
16th May 20244:30 pmRNSTransaction in Own Shares
16th May 202411:07 amRNSNet Asset Value(s)
15th May 20244:38 pmRNSTransaction in Own Shares
15th May 202410:14 amRNSNet Asset Value(s)
14th May 20244:45 pmRNSTransaction in Own Shares
14th May 202412:49 pmRNSNet Asset Value(s)
13th May 20244:50 pmRNSTransaction in Own Shares
13th May 202411:25 amRNSNet Asset Value(s)
10th May 20244:51 pmRNSTransaction in Own Shares
10th May 202411:33 amRNSNet Asset Value(s)
9th May 20244:59 pmRNSTransaction in Own Shares
9th May 202411:46 amRNSNet Asset Value(s)
8th May 20244:44 pmRNSTransaction in Own Shares
8th May 202411:59 amRNSNet Asset Value(s)
7th May 20244:42 pmRNSTransaction in Own Shares
7th May 202411:48 amRNSNet Asset Value(s)
3rd May 202412:50 pmRNSHolding(s) in Company
3rd May 202412:32 pmRNSNet Asset Value(s)
2nd May 20245:09 pmRNSTransaction in Own Shares
2nd May 202412:33 pmRNSNet Asset Value(s)
1st May 20245:18 pmRNSTransaction in Own Shares
1st May 202411:53 amRNSNet Asset Value(s)
1st May 202410:42 amRNSTotal Voting Rights
30th Apr 20245:05 pmRNSTransaction in Own Shares
30th Apr 202412:12 pmRNSNet Asset Value(s)
29th Apr 202412:21 pmRNSNet Asset Value(s)
26th Apr 20244:49 pmRNSTransaction in Own Shares
26th Apr 202411:36 amRNSNet Asset Value(s)
25th Apr 202412:43 pmRNSNet Asset Value(s)
24th Apr 20245:00 pmRNSTransaction in Own Shares
24th Apr 202411:43 amRNSNet Asset Value(s)
23rd Apr 20245:04 pmRNSTransaction in Own Shares
23rd Apr 202411:23 amRNSNet Asset Value(s)
22nd Apr 20245:38 pmRNSTransaction in Own Shares
22nd Apr 202412:09 pmRNSNet Asset Value(s)
19th Apr 20245:11 pmRNSTransaction in Own Shares
19th Apr 202412:02 pmRNSNet Asset Value(s)
18th Apr 20244:57 pmRNSTransaction in Own Shares
18th Apr 20243:25 pmRNSDirector/PDMR Shareholding
18th Apr 20243:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.